Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Skeletal muscle
79%
Transforming Growth Factor-β
77%
Fibrosis
77%
Sarcopenia
64%
Skeletal muscle Atrophy
58%
Muscle Strength
57%
Nonalcoholic Steatohepatitis
55%
Duchenne muscular Dystrophy
48%
Angiotensin-(1-7)
48%
CCN2
47%
Oxidative Stress
44%
Mdx Mice
40%
Metabolic-associated Fatty Liver Disease (MAFLD)
39%
Chronic Liver Disease
38%
Liver
38%
Bile Acids
36%
Connective Tissue Growth Factor
33%
Muscular Dystrophy
32%
Dystrophic muscle
31%
Ubiquitin-proteasome System
31%
Steatotic Liver Disease
30%
Dystrophic
29%
Profibrotic
27%
Skeletal muscle Cells
27%
Myosin Heavy Chain (MyHC)
27%
Hepatocytes
26%
Andrographolide
26%
Mouse Model
25%
High-fat Diet
25%
TGR5
23%
Protein Level
23%
Inflammation
23%
Muscle Fiber
23%
Muscle Wasting
22%
Metabolic
21%
Liver Disease
21%
Steatosis
21%
Liver Disease Progression
21%
Mineralocorticoid Receptor
21%
Muscle Mass
20%
Diet-induced
19%
Myonuclear Apoptosis
19%
Fibroblasts
19%
Decorin
19%
Mas Receptor
18%
Hepatic Stellate Cells
18%
Fatty Acids
18%
Fatty Acid Composition
17%
Reactive Oxygen Species
17%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
98%
Muscle Atrophy
81%
Sarcopenia
67%
Fibrosis
63%
Transforming Growth Factor Beta
63%
Liver Disease
56%
angiotensin[1-7]
50%
Inflammation
40%
Receptor
39%
Chronic Liver Disease
38%
Bile Acid
36%
Reactive Oxygen Metabolite
30%
Fatty Acid
29%
Disease
29%
Muscular Dystrophy
28%
Duchenne Muscular Dystrophy
28%
Myosin Heavy Chain
26%
Connective Tissue Growth Factor
26%
Andrographolide
26%
Somatomedin C
23%
Steatosis
19%
TGF-Beta
19%
Experimental Steatohepatitis
18%
Myofibrosis
18%
Mouse Model
17%
Growth Hormone
17%
Cholic Acid
17%
Deoxycholic Acid
17%
Ethanol
17%
Hypoxia
17%
Fatty Liver
16%
Muscle Disease
15%
Angiotensin
15%
Biological Marker
14%
Inflammasome
14%
Renin
14%
Disease Exacerbation
14%
Triacylglycerol
13%
Proteasome
12%
Ubiquitin
12%
Liver Cell Carcinoma
12%
Acetylcysteine
11%
Glucocorticoid
10%
Apocynin
10%
Prevalence
10%
Cholestasis
10%
Injury
10%
Membrane Receptor
9%
Dipeptidyl Carboxypeptidase
9%
Cancer Growth Factor
9%
Medicine and Dentistry
Nonalcoholic Fatty Liver
93%
Skeletal Muscle
85%
Sarcopenia
55%
Fibrosis
51%
Liver Disease
51%
Transforming Growth Factor Beta
50%
Oxidative Stress
39%
Chronic Liver Disease
34%
Muscle Atrophy
34%
Disease
33%
Muscular Dystrophy
29%
Duchenne Muscular Dystrophy
29%
Fatty Liver
28%
Connective Tissue Growth Factor
28%
Bile Acid
26%
Muscle Strength
24%
Skeletal Muscle Atrophy
24%
Metabolic Dysfunction-Associated Steatotic Liver Disease
23%
High Fat Food
22%
Programmed Cell Death
22%
Steatohepatitis
21%
Non-Alcoholic Fatty Liver Disease
20%
Reactive Oxygen Species
19%
Cell Therapy
18%
Fatty Acid
18%
Mineralocorticoid Receptor
17%
Hepatic Stellate Cell
17%
NMR Spectroscopy
17%
Biological Marker
16%
Signal Transduction
15%
Hepatocyte
15%
Hepatocellular Carcinoma
14%
Somatomedin C
14%
Mitochondrial Disorder
13%
Liver Cirrhosis
12%
Prevalence
12%
Diabetes
11%
Acetylcysteine
11%
Steatosis
11%
Renin Angiotensin Aldosterone System
11%
Heavy Meromyosin
11%
Muscle Disease
10%
Proteasome
10%
Ubiquitin
10%
Myofibrosis
10%
Cholestasis
10%
Innate Immunity
9%
TGF-Beta
9%
Side Effect
9%
Malignant Neoplasm
9%
